Overview
What is Doheny Eye Institute?
The Doheny Eye Institute (DEI) is a renowned nonprofit organization situated in Pasadena, California, dedicated to enhancing human eyesight through research, education, and clinical care. Guided by objectives to expand knowledge of the human eye and its ailments, DEI conducts research on retinal degeneration, molecular genetics of inherited eye diseases, retinal vascular stiffness, and mitochondrial dysfunction. Notably, DEI has initiated collaborations with UCLA for a 99-year affiliation to further their mission. In recent studies, DEI is examining the mechanisms responsible for Age-Related Macular Degeneration (AMD) and developing new therapies using artificial intelligence and gene therapy. Additionally, they have pioneered advanced imaging technologies, such as Adaptive Optics Near-Confocal Ophthalmoscopy (AONCO), to assess retinal microcirculation and detect age- and disease-related changes. The organization's commitment to excellence in ophthalmology care and groundbreaking research continues to drive innovative solutions for improving eyesight.
Official website here: www.doheny.org
Is Doheny Eye Institute legitimate?
Doheny Eye Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Doheny Eye Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $1,539,396
Professional Fundraising Fees: $0
Other Salaries and Wages: $7,877,902
For more financial information, click here
Official website here: www.doheny.org
What is the mission statement of Doheny Eye Institute?
The Doheny Eye Institute is dedicated to advancing knowledge about the human eye, its conditions, and diseases through research. This knowledge is then disseminated through education, training, and community service. The ultimate goal is to facilitate the application of research to improve patient care and foster further research. Research areas with long-term focus include retinal and macular degeneration, molecular genetics of inherited retinal diseases, and retinal vascular stiffness. Recent studies are focused on understanding the mechanisms responsible for age-related macular degeneration and developing new therapies for this disease. The institute also employs cutting-edge imaging technology and artificial intelligence to interpret retinal images and predict disease progression.
Official website here: www.doheny.org
Who is the CEO of Doheny Eye Institute?
Marissa Goldberg is the Ceo & Secretary of Doheny Eye Institute. The CEO's salary of Doheny Eye Institute is $575,272 and their total compensation is $649,069.
Official website here: www.doheny.org
What is the revenue of Doheny Eye Institute?
Who are the executives of Doheny Eye Institute and what are their salaries?
The average compensation at Doheny Eye Institute during 2022 was $61,551. There are 153 employees and 25 volunteers at Doheny Eye Institute.
Here are 21 key members and their salaries (Doheny Eye Institute's CEO's salary is $575,272 and their total compensation is $649,069):
- Marissa Goldberg (Ceo & Secretary) [Trustee/Director]
- Srinivas R Sadda Md (Professor)
- Matthew Mclean Rabin (Chief Development Officer)
- Steven Daniel Macgregor (Director Of Finance)
- Kent Berkeley Tepper (It Director)
- Ram Kannan (Scientist)
- James Gipson (Vice Chairman) [Trustee/Director]
- Charles T Foscue (Chairman) [Trustee/Director]
- Robert L Smith Iii (Director)
- Jay S Wintrob (Director)
- Ronald L Olson (Director)
- Stephen A Ralph (Director)
- Steven E Feldon (Director)
- John R Cleator (Director)
- Kathleen M Duncan (Director)
- James P Edmondson (Director)
- Geoffrey H Gee (Director)
- Diane J Rinker (Director)
- Eric L Small (Director)
- Robert Maloney (Director)
- Mark Samuels (Director)
Official website here: www.doheny.org
Where can I find the form 990 for Doheny Eye Institute?
The Doheny Eye Institute’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.doheny.org
Learn more at the official website: www.doheny.org
Mission Statement of Doheny Eye Institute
The Doheny Eye Institute, a leading nonprofit organization, is dedicated to the conservation, improvement, and restoration of human eyesight. Established in the spirit of Mrs. Doheny's vision in 1947, this institute aims to increase knowledge of the human eye and its conditions and diseases through rigorous research. Guided by this objective, Doheny Eye Institute conducts research on retinal degeneration, including age-related macular degeneration (AMD), and explores the use of advanced retinal imaging and artificial intelligence for diagnosis and treatment.
The organization's mission extends beyond research. It also involves the transmission of acquired knowledge through education, training, and community service. Doheny Eye Institute's research activities, such as studies on retinal pigment epithelium, molecular genetics of inherited retinal diseases, and retinal vascular stiffness, are focused on improving patient care and fostering further research. By applying the findings of their studies, they aim to develop new therapies for AMD and other eye diseases.
Doheny Eye Institute's researchers are currently investigating the mechanisms responsible for the development of AMD, a leading cause of blindness in individuals over 60 years old in the US. They are studying retinal cells from patients with specific genetic defects in genes involved in the immune system and another gene of unknown function but with a significant impact on AMD. The insights gained from these studies will be critical in developing new therapies for AMD that target the root cause of the disease.
Additionally, Doheny Eye Institute scientists are using artificial intelligence to develop faster ways to interpret retinal images and predict new Stargardt atrophy or progression over time. They have also developed cutting-edge imaging technology, such as an adaptive optics near-confocal ophthalmoscope, which enables precise evaluation of the dynamic movement of erythrocytes within retinal capillaries and helps gain a better understanding of the higher-order hemodynamics in normal human retinal capillaries. This research is essential as it will lead to the development of new biomarkers for detecting age- and disease-related changes in the retinal microcirculation.
Impact
This information is meant to be a general summary of Doheny Eye Institute. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Doheny Eye Institute is making a significant impact in the field of ophthalmology by conducting cutting-edge research to further the conservation, improvement, and restoration of human eyesight. Through their research activities, such as studying retinal and macular degeneration using advanced imaging and artificial intelligence, investigating molecular genetics of inherited retinal diseases, and exploring new imaging technologies, DEI is at the forefront of advancements in understanding and treating eye diseases.
By focusing on key areas such as age-related macular degeneration, gene therapy for retinal disorders, and the effects of oxidative stress on retinal cells, DEI is contributing valuable insights that could lead to the development of new therapies for sight-threatening conditions. Their interdisciplinary approach, bridging genetics, vascular biology, and imaging techniques, has the potential to uncover previously unrecognized mechanisms underlying common ocular diseases such as diabetic retinopathy and age-related macular degeneration.
Overall, the Doheny Eye Institute's commitment to research, education, and clinical care in partnership with UCLA demonstrates their dedication to improving patient care, advancing scientific knowledge, and ultimately making a positive impact on the conservation and restoration of human eyesight.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CONTRACTS
Revenue
$4,786,351
PASS THROUGH AWARDS
Revenue
$326,017
OTHER REVENUE
Revenue
$70,842
Organization Details
Founding Year
1947
Phone
(323) 342-7100
Principal Officer
Marissa Goldberg
Main Address
PO BOX 86228, LOS ANGELES, CA, 90086
Website
www.doheny.org
NTEE Category
Code: G40 - Disease
If you are a representative of Doheny Eye Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.